Stay updated on SubQ Efgartigimod in CIDP Clinical Trial

Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Add: new operating-status notice and a new version tag v3.2.0. Delete: removal of a specific resource entry (Chronic inflammatory demyelinating polyradiculoneuropathy) and an older version tag v3.0.2. Overall, the page now signals current status and a more recent release, with a different resource mention.
    Difference
    2%
    Check dated 2025-10-02T08:08:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Removed four MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); overall breadth of content is reduced.
    Difference
    0.2%
    Check dated 2025-09-25T02:27:48.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    No substantive changes detected; only the removal of a 'Back to Top' link. The core content and other critical information remain unchanged.
    Difference
    0.1%
    Check dated 2025-09-17T22:24:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 with a Back to Top link added. The legacy v3.0.0-post.1 tag was removed.
    Difference
    0.1%
    Check dated 2025-09-10T18:18:07.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, specifically from v3.0.0 to v3.0.0-post.1-g752effb-HEAD.
    Difference
    0.0%
    Check dated 2025-09-03T14:39:38.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and location details, as well as a comprehensive list of publications related to chronic inflammatory demyelinating polyradiculoneuropathy. Additionally, several outdated location entries have been removed.
    Difference
    10%
    Check dated 2025-08-27T10:14:08.000Z thumbnail image

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.